NVAX NOVAVAX INC US FDA Inspections 8-K Filing 2024 - FDA Update Novavax announced that the FDA has lifted the clinical hold on its Investigational New Drug Application for its COVID-19-Influenza Combination and stand-alone influenza vaccine candidates, which had been placed on October 16, 2024.Get access to all SEC 8-K filings of the NOVAVAX INC